References
1. March of Dimes, PMNCH, Save the Children, WHO. Born Too Soon: The
Global Action Report on Preterm Birth. Geneva; 2012.
2. Collins J. Global epidemiology of multiple birth. Reprod Biomed
Online. 2007;15 Suppl 3:45–52.
3. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G,
Bottoms S, et al. The preterm prediction study: risk factors in twin
gestations. National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996
Oct;175(4 Pt 1):1047–53.
4. Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH. Cervical
length at 23 weeks in twins in predicting spontaneous preterm delivery.
Obstet Gynecol. 1999 Sep;94(3):450-4. doi:
10.1016/s0029-7844(99)00277-x. PMID: 10472876.
5. EPPPIC Group. Evaluating Progestogens for Preventing Preterm birth
International Collaborative (EPPPIC): meta-analysis of individual
participant data from randomized controlled trials. Lancet 2021
Mar;397(10280):1183–94. doi: 10.1016/S0140-6736(21)00217-8. Erratum in:
Lancet. 2021 Apr 17;397(10283):1446. PMID: 33773630.
6. D’Antonio F, Berghella V, Di Mascio D, Saccone G, Sileo F, Flacco ME,
et al. Role of progesterone, cerclage and pessary in preventing preterm
birth in twin pregnancies: A systematic review and network
meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021 Jun;261:166–77
7. El-Refaie W, Abdelhafez MS, Badawy A. Retraction Note: Vaginal
progesterone for prevention of preterm labor in asymptomatic twin
pregnancies with sonographic short cervix: a randomized clinical trial
of efficacy and safety. Arch Gynecol Obstet. 2021 Oct;304(4):1113.
8. Pacagnella RC, Silva TV, Cecatti JG, Passini R Jr, Fanton TF,
Borovac-Pinheiro A, et al. Pessary Plus Progesterone to Prevent Preterm
Birth in Women With Short Cervixes: A Randomized Controlled Trial.
Obstet Gynecol. 2022 Jan 1;139(1):41-51. doi:
10.1097/AOG.0000000000004634. PMID: 34856583.
9. Groussolles M, Winer N, Sentilhes L, Biquart F, Massoud M, Vivanti
AJ,
et al. Arabin pessary to prevent adverse perinatal outcomes in twin
pregnancies with a short cervix: a multicenter randomized controlled
trial (PESSARONE). Am J Obstet Gynecol. 2022 Aug;227(2):271.e1-271.e13.
doi: 10.1016/j.ajog.2022.01.038. Epub 2022 Feb 3. PMID: 35123930.
10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD,
et al. The PRISMA 2020 statement: an updated guideline for reporting
systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
PMID: 33782057; PMCID: PMC8005924.
11. Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, et
al. Cervical pessaries for prevention of preterm birth in women with a
multiple pregnancy (ProTWIN): a multicentre, open-label randomised
controlled trial. Lancet. 2013 Oct 19;382(9901):1341-9. doi:
10.1016/S0140-6736(13)61408-7. Epub 2013 Aug 5. PMID: 23924878.
12. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I,
et al. RoB 2: a revised tool for assessing risk of bias in randomised
trials. BMJ 2019; 366: l4898
13. Ben W. Mol, Shimona Lai, Ayesha Rahim, Wentao Li. A Screening
Checklist to Assess Data Integrity and Fabrication in Randomized
Clinical Trials. Ninth International Congress on Peer Review and
Scientific Publication, September 8-10, 2022.
14. Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del
Giovane C, Egger M, et al. CINeMA: An approach for assessing confidence
in the results of a network meta-analysis. PLoS Med. 2020 Apr
3;17(4):e1003082. doi: 10.1371/journal.pmed.1003082. PMID: 32243458;
PMCID: PMC7122720.
15. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY,
et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent
prematurity in twins. N Engl J Med. 2007 Aug 2;357(5):454-61. doi:
10.1056/NEJMoa070641. PMID: 17671253.
16. Awwad J, Usta IM, Ghazeeri G, Yacoub N, Succar J, Hayek S, et al. A
randomised controlled double-blind clinical trial of
17-hydroxyprogesterone caproate for the prevention of preterm birth in
twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
BJOG. 2015 Jan;122(1):71-9. doi: 10.1111/1471-0528.13031. Epub 2014 Aug
27. PMID: 25163819.
17. Crowther CA, Ashwood P, McPhee AJ, Flenady V, Tran T, Dodd JM, et
al. Vaginal progesterone pessaries for pregnant women with a previous
preterm birth to prevent neonatal respiratory distress syndrome (the
PROGRESS Study): A multicentre, randomised, placebo-controlled trial.
PLoS Med. 2017 Sep 26;14(9):e1002390. doi: 10.1371/journal.pmed.1002390.
PMID: 28949973; PMCID: PMC5614421.
18. Aboulghar MM, El-Faissal Y, Kamel A, Mansour R, Serour G, Aboulghar
M, et al. The effect of early administration of rectal progesterone in
IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial.
BMC Pregnancy Childbirth. 2020 Jun 9;20(1):351. doi:
10.1186/s12884-020-03033-4. PMID: 32517660; PMCID: PMC7285559.
19. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et
al. Progesterone for the prevention of preterm birth in twin pregnancy
(STOPPIT): a randomised, double-blind, placebo-controlled study and
meta-analysis. Lancet. 2009 Jun 13;373(9680):2034-40. doi:
10.1016/S0140-6736(09)60947-8. PMID: 19523680.
20. Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix
Collaborative Research Network. Failure of 17-hydroxyprogesterone to
reduce neonatal morbidity or prolong triplet pregnancy: a double-blind,
randomized clinical trial. Am J Obstet Gynecol. 2010
Sep;203(3):248.e1-9. doi: 10.1016/j.ajog.2010.06.016. Erratum in: Am J
Obstet Gynecol. 2011 Feb;204(2):166. PMID: 20816146.
21. Hajizadeh N, Saharkhiz N, Hosseini S, Arabzadeh B. Comparison of
cerclage and pessary in prevention of preterm birth in twin pregnancies.
Med J Islam Repub Iran. 2020 Jul 6;34:74. doi: 10.34171/mjiri.34.74.
PMID: 33306065; PMCID: PMC7711049.
22. Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A;
PREDICT Group. Vaginal micronized progesterone and risk of preterm
delivery in high-risk twin pregnancies: secondary analysis of a
placebo-controlled randomized trial and meta-analysis. Ultrasound Obstet
Gynecol. 2011 Sep;38(3):281-7. doi: 10.1002/uog.9092. PMID: 21739499.
23. Caritis SN, Simhan HN, Zhao Y, Rouse DJ, Peaceman AM, Sciscione A,
et al. Relationship between 17-hydroxyprogesterone caproate
concentrations and gestational age at delivery in twin gestation. Am J
Obstet Gynecol. 2012 Nov;207(5):396.e1-8. doi:
10.1016/j.ajog.2012.08.001. Epub 2012 Aug 6. PMID: 22959763; PMCID:
PMC3484214.
24. Merced C, Goya M, Pratcorona L, Rodó C, Llurba E, Higueras T, et al.
Cervical pessary for preventing preterm birth in twin pregnancies with
maternal short cervix after an episode of threatened preterm labor:
randomised controlled trial. Am J Obstet Gynecol. 2019
Jul;221(1):55.e1-55.e14. doi: 10.1016/j.ajog.2019.02.035. Epub 2019 Feb
28. Erratum in: Am J Obstet Gynecol. 2021 May;224(5):532. PMID:
30826339.
25. El-Refaie W, Abdelhafez MS, Badawy A. Vaginal progesterone for
prevention of preterm labor in asymptomatic twin pregnancies with
sonographic short cervix: a randomized clinical trial of efficacy and
safety. Arch Gynecol Obstet. 2016 Jan;293(1):61-67. doi:
10.1007/s00404-015-3767-1. Epub 2015 Jun 5. Retraction in: Arch Gynecol
Obstet. 2021 Oct;304(4):1113. PMID: 26044148.
26. Cetingoz E, Cam C, Sakallı M, Karateke A, Celik C, Sancak A.
Progesterone effects on preterm birth in high-risk pregnancies: a
randomized placebo-controlled trial. Arch Gynecol Obstet. 2011
Mar;283(3):423-9. doi: 10.1007/s00404-009-1351-2. Epub 2010 Jan 22.
PMID: 20091317.
27. Abdel Wahab AS, Abdelmonaem MI, Mahmoud WM, Mansour AE. A randomized
controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for
prevention of preterm labor in twin gestations. J Perinat Med. 2021 Sep
14. doi: 10.1515/jpm-2021-0131. Epub ahead of print. PMID: 34523303.
28. Rust OA, Atlas RO, Jones KJ, Benham BN, Balducci J. A randomized
trial of cerclage versus no cerclage among patients with
ultrasonographically detected second-trimester preterm dilatation of the
internal os. Am J Obstet Gynecol. 2000 Oct;183(4):830-5. doi:
10.1067/mob.2000.109040. PMID: 11035321.
29. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention of preterm
birth in women with a short cervix found on transvaginal ultrasound
examination: a randomized trial. Am J Obstet Gynecol. 2004
Oct;191(4):1311-7. doi: 10.1016/j.ajog.2004.06.054. PMID: 15507959.
30. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine
Foundation Second Trimester Screening Group. Progesterone and the risk
of preterm birth among women with a short cervix. N Engl J Med. 2007 Aug
2;357(5):462-9. doi: 10.1056/NEJMoa067815. PMID: 17671254.
31. Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A;
PREDICT Group. Prevention of preterm delivery in twin gestations
(PREDICT): a multicenter, randomized, placebo-controlled trial on the
effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol.
2011 Sep;38(3):272-80. doi: 10.1002/uog.9093. PMID: 21739497.
32. Aboulghar MM, Aboulghar MA, Amin YM, Al-Inany HG, Mansour RT, Serour
GI. The use of vaginal natural progesterone for prevention of preterm
birth in IVF/ICSI pregnancies. Reprod Biomed Online. 2012
Aug;25(2):133-8. doi: 10.1016/j.rbmo.2012.03.013. Epub 2012 Apr 3. PMID:
22695310.
33. Wood S, Ross S, Tang S, Miller L, Sauve R, Brant R. Vaginal
progesterone to prevent preterm birth in multiple pregnancy: a
randomized controlled trial. J Perinat Med. 2012 Nov;40(6):593-9. doi:
10.1515/jpm-2012-0057. PMID: 23093256.
34. Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, et
al. Increased doses of vaginal progesterone for the prevention of
preterm birth in twin pregnancies: a randomised controlled double-blind
multicentre trial. BJOG. 2013 Jan;120(1):50-7. doi:
10.1111/j.1471-0528.2012.03448.x. Epub 2012 Aug 13. PMID: 22882759.
35. Brizot ML, Hernandez W, Liao AW, Bittar RE, Francisco RPV, Krebs
VLJ, et al. Vaginal progesterone for the prevention of preterm birth in
twin gestations: a randomized placebo-controlled double-blind study. Am
J Obstet Gynecol. 2015 Jul;213(1):82.e1-82.e9. doi:
10.1016/j.ajog.2015.02.021. Epub 2015 Feb 27. PMID: 25731690.
36. Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero
S, et al. Early vaginal progesterone versus placebo in twin pregnancies
for the prevention of spontaneous preterm birth: a randomized,
double-blind trial. Am J Obstet Gynecol. 2021 Jan;224(1):86.e1-86.e19.
doi: 10.1016/j.ajog.2020.06.050. Epub 2020 Jun 26. PMID: 32598909.
37. Briery CM, Veillon EW, Klauser CK, Martin RW, Magann EF, Chauhan SP,
et al. Women with preterm premature rupture of the membranes do not
benefit from weekly progesterone. Am J Obstet Gynecol. 2011
Jan;204(1):54.e1-5. doi: 10.1016/j.ajog.2010.08.022. PMID: 20869038.
38. Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM,
Sciscione A. Se, et al. Second trimester cervical length and risk of
preterm birth in women with twin gestations treated with 17-α
hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2010
Dec;23(12):1360-4. doi: 10.3109/14767051003702786. Epub 2010 May 4.
PMID: 20441408; PMCID: PMC2999406.
39. Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix
Collaborative Research Network. 17-hydroxyprogesterone caproate for twin
pregnancy: a double-blind, randomized clinical trial. Am J Obstet
Gynecol. 2011 Mar;204(3):221.e1-8. doi: 10.1016/j.ajog.2010.12.042.
PMID: 21376161.
40. Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich
JJHM, et al. 17α-hydroxyprogesterone caproate for the prevention of
adverse neonatal outcome in multiple pregnancies: a randomized
controlled trial. Obstet Gynecol. 2011 Sep;118(3):513-520. doi:
10.1097/AOG.0b013e31822ad6aa. PMID: 21860279.
41. Senat MV, Porcher R, Winer N, Vayssière C, Deruelle P, Capelle M, et
al. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone
caproate in asymptomatic twin pregnancies with a short cervix: a
randomized controlled trial. Am J Obstet Gynecol. 2013
Mar;208(3):194.e1-8. doi: 10.1016/j.ajog.2013.01.032. PMID: 23433324.
42. Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, et
al. Cervical pessaries for prevention of preterm birth in women with a
multiple pregnancy (ProTWIN): a multicentre, open-label randomised
controlled trial. Lancet. 2013 Oct 19;382(9901):1341-9. doi:
10.1016/S0140-6736(13)61408-7. Epub 2013 Aug 5. PMID: 23924878.
43. Nicolaides KH, Syngelaki A, Poon LC, de Paco Matallana C, Plasencia
W, Molina FS, et al. Cervical pessary placement for prevention of
preterm birth in unselected twin pregnancies: a randomized controlled
trial. Am J Obstet Gynecol. 2016 Jan;214(1):3.e1-9. doi:
10.1016/j.ajog.2015.08.051. Epub 2015 Aug 28. PMID: 26321037.
44. Goya M, de la Calle M, Pratcorona L, Merced C, Rodó C, Muñoz B, et
al; PECEP-Twins Trial Group. Cervical pessary to prevent preterm birth
in women with twin gestation and sonographic short cervix: a multicenter
randomized controlled trial (PECEP-Twins). Am J Obstet Gynecol. 2016
Feb;214(2):145-152. doi: 10.1016/j.ajog.2015.11.012. Epub 2015 Nov 25.
PMID: 26627728.
45. Berghella V, Dugoff L, Ludmir J. Prevention of preterm birth with
pessary in twins (PoPPT): a randomized controlled trial. Ultrasound
Obstet Gynecol. 2017 May;49(5):567-572. doi: 10.1002/uog.17430. PMID:
28170117.
46. Norman JE, Norrie J, MacLennan G, Cooper D, Whyte S, Chowdhry S, et
al. Evaluation of the Arabin cervical pessary for prevention of preterm
birth in women with a twin pregnancy and short cervix (STOPPIT-2): An
open-label randomised trial and updated meta-analysis. PLoS Med. 2021
Mar 29;18(3):e1003506. doi: 10.1371/journal.pmed.1003506. PMID:
33780463; PMCID: PMC8041194.
47. Dang VQ, Nguyen LK, Pham TD, He YTN, Vu KN, Phan MTN, et al. Pessary
Compared With Vaginal Progesterone for the Prevention of Preterm Birth
in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A
Randomized Controlled Trial. Obstet Gynecol. 2019 Mar;133(3):459-467.
doi: 10.1097/AOG.0000000000003136. PMID: 30741812.